| Literature DB >> 31262364 |
Anna Sarocka1, Veronika Kovacova1, Radoslav Omelka2, Birgit Grosskopf3, Edyta Kapusta4, Zofia Goc4, Grzegorz Formicki4, Monika Martiniakova1.
Abstract
BACKGROUND: This study aimed to examine femoral bone microstructure of mice after single and simultaneous administration to acrylamide and ethanol since both substances are often consumed separately and/or together by humans. Interactive effects of these toxins were analysed after one remodeling cycle.Entities:
Keywords: Acrylamide; Cortical bone; Ethanol; Liver; Mice; Trabecular bone
Mesh:
Substances:
Year: 2019 PMID: 31262364 PMCID: PMC6604442 DOI: 10.1186/s40360-019-0317-7
Source DB: PubMed Journal: BMC Pharmacol Toxicol ISSN: 2050-6511 Impact factor: 2.483
Fig. 1Representative 2D and 3D images of cortical and trabecular bone tissues in mice a microscopic structure of cortical bone in control mice. b microscopic structure of cortical bone in mice receiving 40 mg/kg bw acrylamide. c microscopic structure of cortical bone in mice receiving 15% ethanol. d microscopic structure of cortical bone in mice receiving both toxins.1 non-vascular bone tissue. 2 isolated intact secondary osteons. 3 resorption lacunae. e representative reconstructed 3D image of the cortical bone in control mice. f representative reconstructed 3D image of the cortical bone in mice receiving 40 mg/kg bw acrylamide. g representative reconstructed 3D image of the cortical bone in mice receiving 15% ethanol. h representative reconstructed 3D image of the cortical bone in mice receiving both toxins. i representative reconstructed 3D image of the trabecular bone in control mice. j representative reconstructed 3D image of the trabecular bone in mice receiving 40 mg/kg bw acrylamide. k representative reconstructed 3D image of the trabecular bone in mice receiving 15% ethanol. l representative reconstructed 3D image of the trabecular bone in mice receiving both toxins
Quantitative 2D analysis of cortical bone tissue
| Measured structures | Group | n | Area | Perimeter | Mean. diameter (μm) |
|---|---|---|---|---|---|
| Primary osteons’ vascular canals | C (1) | 202 | 31.237 ± 4.453 | 19.841 ± 1.387 | 3.152 ± 0.275 |
| A (2) | 160 | 24.223 ± 3.802 | 17.484 ± 1.377 | 2.761 ± 0.271 | |
| E (3) | 190 | 37.823 ± 5.445 | 21.814 ± 1.569 | 3.475 ± 0.312 | |
| AE (4) | 140 | 27.038 ± 5.113 | 18.426 ± 1.751 | 2.915 ± 0.325 | |
| Games-Howell’s test | 1:2*;1:3*;1:4*; 2:3*;3:4*;2:4* | 1:2*;1:3*;1:4*; 2:3*;3:4*;2:4* | 1:2*;1:3*;1:4*; 2:3*;3:4*;2:4* | ||
| Haversian canals | C (1) | 15 | 25.393 ± 4.083 | 18.027 ± 1.412 | 2.842 ± 0.301 |
| A (2) | 23 | 21.311 ± 4.681 | 16.331 ± 1.821 | 2.575 ± 0.332 | |
| E (3) | 22 | 22.009 ± 3.639 | 16.681 ± 1.382 | 2.625 ± 0.275 | |
| AE (4) | 29 | 19.061 ± 4.535 | 15.457 ± 1.813 | 2.431 ± 0.331 | |
| Games-Howell’s test | 1:2*; 1:3*; 1:4* | 1:2*; 1:3*; 1:4* | 1:2*; 1:3*; 1:4* | ||
| Secondary osteons | C (1) | 15 | 296.011 ± 43.926 | 61.227 ± 4.357 | 9.725 ± 0.895 |
| A (2) | 23 | 267.056 ± 51.369 | 58.796 ± 5.425 | 9.275 ± 0.971 | |
| E (3) | 22 | 248.959 ± 55.878 | 56.041 ± 6.321 | 8.885 ± 1.112 | |
| AE (4) | 29 | 250.676 ± 47.697 | 56.535 ± 5.397 | 8.951 ± 1.045 | |
| Tukey’s test | 1:3* | 1:3* | 1:2*;1:3*;2:3*;1:4* | ||
n number of measurements, C control mice, A mice receiving acrylamide, E mice receiving ethanol, AE mice receiving both toxins; P < 0.05 (*)
Quantitative 3D analysis of cortical bone tissue
| Group | n | BMD | BV/TV | Bs. | Ct.Th. |
|---|---|---|---|---|---|
| C (1) | 5 | 579.541 ± 61.011 | 0.951 ± 0.012 | 4.291 ± 2.092 | 0.181 ± 0.014 |
| A (2) | 5 | 504.534 ± 54.581 | 0.961 ± 0.012 | 1.141 ± 1.114 | 0.211 ± 0.022 |
| E (3) | 5 | 490.332 ± 23.231 | 0.924 ± 0.024 | 4.561 ± 0.962 | 0.151 ± 0.011 |
| AE (4) | 5 | 470.051 ± 14.734 | 0.961 ± 0.012 | 0.704 ± 0.232 | 0.194 ± 0.012 |
| ANOVA - test | 1:3*;1:4* | 1:3*;2:3*;3:4* | 2:3*;3:4* | 2:3*;3:4* | |
n number of measurements, C control mice, A mice receiving acrylamide, E mice receiving ethanol, AE mice receiving both toxins, BMD bone mineral density, BV/TV relative bone volume, Bs. bone surface, Ct. Th. cortical bone thickness; P < 0.05 (*)
Fig. 2Quantitative 3D analysis of cortical bone tissue
Quantitative 3D analysis of trabecular bone tissue
| Group | n | BV/TV | BMD | Tb.N. | Tb.Th. | Bs. |
|---|---|---|---|---|---|---|
| C (1) | 5 | 0.113 ± 0.032 | 381.843 ± 33.092 | 4.712 ± 0.591 | 0.042 ± 0.011 | 16.473 ± 4.351 |
| A (2) | 5 | 0.132 ± 0.043 | 357.931 ± 38.092 | 5.083 ± 0.952 | 0.0432 ± 0.011 | 23.43 ± 10.811 |
| E (3) | 5 | 0.083 ± 0.032 | 347.773 ± 55.382 | 4.412 ± 0.741 | 0.041 ± 0.012 | 12.553 ± 4.291 |
| AE (4) | 5 | 0.103 ± 0.032 | 319.472 ± 23.461 | 4.573 ± 0.642 | 0.043 ± 0.012 | 20.042 ± 9.091 |
| ANOVA - test | NS | NS | NS | NS | NS | |
n number of measurements, C control mice, A mice receiving acrylamide, E mice receiving ethanol, AE mice receiving both toxins, BV/TV relative bone volume, BMD bone mineral density, Tb. N. trabecular number, Tb. Th. trabecular thickness, Bs. bone surface, NS non-significant differences
Fig. 3Quantitative 3D analysis of trabecular bone tissue
Biochemical analyses
| Group | n | ALP | ALT | AST | GSH (μmol/mg protein) | Ca |
|---|---|---|---|---|---|---|
| C (1) | 5 | 152.441 ± 9.902 | 7.123 ± 0.561 | 32.811 ± 5.483 | 3.512 ± 0.214 | 83.941 ± 3.501 |
| A (2) | 5 | 144.162 ± 8.312 | 12.101 ± 0.521 | 58.371 ± 5.972 | 2.441 ± 0.243 | 92.101 ± 4.342 |
| E (3) | 5 | 44.292 ± 2.601 | 17.511 ± 1.742 | 42.321 ± 5.721 | 2.672 ± 0.212 | 73.661 ± 2.863 |
| AE (4) | 5 | 79.612 ± 6.821 | 11.952 ± 1.331 | 59.132 ± 4.721 | 2.921 ± 0.362 | 84.911 ± 3.743 |
| ANOVA - test | 1:3*;1:4*; 2:3*;2:4*; 3:4* | 1:2*;1:3*; 1:4*;2:3*; 3:4* | 1:2*;1:3*; 1:4*;2:3*; 3:4* | 1:2*;1:3*; 1:4* | 1:2*;1:3*; 2:3*;2:4*; 3:4* | |
n number of measurements, C control mice, A mice receiving acrylamide, E mice receiving ethanol, AE mice receiving both toxins, ALP alkaline phosphatase, ALT alanine aminotransferase, AST asparate aminotransferase, GSH glutathione, Ca calcium; P < 0.05 (*)
Fig. 4Biochemical analyses